AbCellera
AbCellera provides biotech and pharma partners with enabling technologies for the discovery and development of monoclonal antibody (mAb) therapies directly from natural immune cells.
Employees
586
City
Vancouver
Province
British Columbia
AbCellera provides biotech and pharma partners with enabling technologies for the discovery and development of monoclonal antibody (mAb) therapies directly from natural immune cells.